|Day Low/High||1.98 / 2.10|
|52 Wk Low/High||1.53 / 9.09|
The Technology is a Candidate to Treat Emerging Bioterror and Pandemic Threats
Results will add to Published Data Involving Candidate Biomarker to Identify & Monitor CTE
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that James A.